|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 170 JPY | -1.16% |
|
-2.30% | -31.17% |
SymBio Pharmaceuticals Limited provided earnings guidance for the Fiscal Year 2024. For the year, the company now expects Net Sales to be JPY 3,641 million. Operating loss to be JPY 2,837 million.
Loss attributable to owner of parent to be JPY 2,870 million. Loss per share to be JPY 71.93 per share.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.17% | 51.17M | |
| +31.52% | 690B | |
| +25.04% | 546B | |
| -5.21% | 358B | |
| +17.02% | 323B | |
| +5.01% | 287B | |
| +14.04% | 235B | |
| +5.38% | 199B | |
| -9.90% | 195B | |
| +3.98% | 161B |
SYMBIO PHARMACEUTICALS LIMITED 